UNSPSC 51442437: Sodium iodide i-123

This classification denotes a sodium iodide radioactive with the molecular formula I.NA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 29UKX3A616. The term sodium iodide i 123 is a U.S. FDA designation. As of Q4 2014, SODIUM IODIDE I-123 remains the US FDA Preferred Term for this commodity. Sodium iodide i-123 bears US NLM identifiers UMLS ID C0304977 and NCI Concept Code C47724. SMILES: [NA+].[123I-].

UNSPSC 51442437 Sodium iodide i-123, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal pharmaceutical-chemical scope. The two most recent opportunities tagged to this code—a Broward County Aviation Department RFI for Rapiscan X-ray system maintenance services (posted June 25, 2026) and a Pasco County, Florida RFQ for copper sulfate supply (posted June 3, 2026)—are unrelated to sodium iodide or radiopharmaceuticals. The X-ray maintenance RFI addresses specialized inspection-system repair for airport security applications, while the copper sulfate RFQ addresses industrial chemical supply; neither opportunity involves the isotope or medical-imaging products the code nominally covers. The issuing bodies represent county-level jurisdictions with distinct operational needs, but lack coherence around the code's intended scope.

Geographic activity centers on Florida based on these two recent records, though the sample is too sparse and misaligned to establish meaningful geographic concentration. No recent opportunities in the source substantiate active state or local procurement of sodium iodide i-123 or related radiopharmaceuticals. The code shows little relevant recent activity; if your firm supplies radiopharmaceuticals, medical isotopes, or nuclear-medicine products, do not rely on this code as a reliable targeting mechanism for state and local opportunities in its nominal category.